BIOGEN INC. (BIIB) Operating cash flow 2016–2025
BIOGEN INC. (BIIB) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.2BFY2025 · since FY2016: $4.6B → $2.2B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.2B | -23.3% |
| FY2024 | $2.9B | +85.9% |
| FY2023 | $1.5B | +11.8% |
| FY2022 | $1.4B | -62.0% |
| FY2021 | $3.6B | -13.9% |
| FY2020 | $4.2B | -40.2% |
| FY2019 | $7.1B | +14.4% |
| FY2018 | $6.2B | +36.0% |
| FY2017 | $4.6B | -0.8% |
| FY2016 | $4.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More BIIB financial trends
BIIB RevenueBIIB Net incomeBIIB Net marginBIIB Gross profitBIIB Gross marginBIIB Operating incomeBIIB Operating marginBIIB Free cash flowBIIB Capital expendituresBIIB Return on equityBIIB Stock buybacksBIIB Dividends paidBIIB Total assetsBIIB Total liabilitiesBIIB Shareholders’ equityBIIB overview →